Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

Share Price is delayed by 15 minutes
Get Live Data
23.85    -0.30 (-1.24%)
Bid:
23.80
Ask:
23.90
Spread: 0.10 (0.42%)
Market Cap: £443.87m
ENQ Live PriceLast checked at - London Stock Exchange

Intraday Enquest Share Chart

Transaction in Own Shares

23 Sep 2024 07:00

RNS Number : 1348F
EnQuest PLC
23 September 2024
 

FOR IMMEDIATE RELEASE 23 September 2024

 

ENQUEST PLC ("EnQuest" or "the Company")

TRANSACTIONS IN OWN SHARES

EnQuest PLC (the "Company") announces that, on 20 September 2024, it purchased the following number of its ordinary shares of 5 pence each (the "Ordinary Shares") through Merrill Lynch International ("Merrill Lynch"). Such purchase was effected pursuant to the instructions issued by the Company in accordance with the share repurchase arrangements entered into with Merrill Lynch, as announced on 29 April 2024.

Aggregated information of Ordinary Shares purchased on 20 September 2024 according to each trading venue:

Venue

Weighted average price paid per share (GBp)

Aggregate number of shares purchased

Lowest price paid per share (GBp)

Highest price paid per share (GBp)

London Stock Exchange

11.40

599,000

11.20

11.60

Chi-X

11.40

30,032

11.30

11.54

BATS

11.35

14,221

11.30

11.48

Turquoise

-

0

-

-

Total (all venues)

11.39

643,253

11.20

11.60

 

Since 29 April 2024, the Company has purchased 33,295,887 Ordinary Shares at a cost (including dealing and associated costs) of £4,489,790.95. Of those shares, 25,000,000 Ordinary Shares have been retained in Treasury and will be issued in due course to the Company's Employee Benefit Trust and 8,295,887 Ordinary Shares have been purchased for cancellation.

Following the cancellation of the purchased shares, there will be 1,907,628,452 Ordinary Shares in issue and 25,000,000 Shares in Treasury. The total voting rights in the Company will accordingly be 1,882,628,452. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

A full breakdown of the individual trades made by Merrill Lynch on behalf of the Company as part of the share repurchase programme is attached to this document.

Attachment: http://www.rns-pdf.londonstockexchange.com/rns/1348F_1-2024-9-21.pdf

 

LEI: 2138008LJU6WFQWOXJ73

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

Enquiries:

 

EnQuest plc +44 (0)20 7925 4900

Kate Christ, Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBXGDCUDDDGSB
Date   Source Headline
21st Oct 201910:11 amRNSDirector/PDMR Shareholding
18th Oct 201910:25 amRNSTotal Voting Rights
11th Oct 201912:13 pmRNSDirector/PDMR Shareholding
9th Oct 20194:27 pmRNSDirector/PDMR Shareholding
2nd Oct 20191:08 pmRNSDirector/PDMR Shareholding
17th Sep 201911:25 amRNSHolding(s) in Company
16th Sep 201911:13 amRNSDirector/PDMR Shareholding
9th Sep 201911:44 amRNSDirector/PDMR Shareholding
5th Sep 20197:00 amRNSChairman Succession
5th Sep 20197:00 amRNSResults for the six months ended 30 June 2019
2nd Sep 201912:04 pmRNSHolding(s) in Company
28th Aug 20193:22 pmRNSTotal Voting Rights
29th Jul 20199:27 amRNSTotal Voting Rights
17th Jul 201911:30 amRNSDirector/PDMR Shareholding
12th Jul 20193:00 pmRNSDirector/PDMR Shareholding
9th Jul 20199:15 amRNSDirector/PDMR Shareholding
1st Jul 20192:48 pmRNSDirector/PDMR Shareholding
27th Jun 20192:24 pmRNSReport on Payments to Govts
26th Jun 201911:54 amRNSTotal Voting Rights
25th Jun 20193:46 pmRNSDirector/PDMR Shareholding
18th Jun 201911:30 amRNSDirector/PDMR Shareholding
10th Jun 20192:33 pmRNSDirector/PDMR Shareholding
5th Jun 20194:12 pmRNSDirector/PDMR Shareholding
3rd Jun 201912:08 pmRNSDirector/PDMR Shareholding
30th May 20198:30 amRNSBlock Listing Application
28th May 20194:28 pmRNSDirector/PDMR Shareholding
23rd May 20194:54 pmRNSAGM Statement
23rd May 20197:00 amRNSOperations Update
20th May 20193:10 pmRNSDirector/PDMR Shareholding
13th May 20194:15 pmRNSDirector/PDMR Shareholding
8th May 201912:50 pmRNSDirector/PDMR Shareholding
26th Apr 20194:34 pmRNSDirector/PDMR Shareholding
17th Apr 20194:00 pmRNSNotice of AGM and Report & Accounts
8th Apr 201910:20 amRNSDirector/PDMR Shareholding
1st Apr 201911:36 amRNSDirector/PDMR Shareholding
27th Mar 20192:35 pmRNSDirector/PDMR Shareholding
21st Mar 20197:00 amRNSFinal Results
15th Mar 20197:00 amRNSBoard Appointment
12th Mar 20197:11 amRNSKraken 2P Reserves
5th Feb 20197:00 amRNSOperations update
30th Jan 20193:22 pmRNSBoard Committee Membership
28th Jan 201911:31 amRNSChange of Directors' Details
23rd Jan 201910:08 amRNSHolding(s) in Company
18th Jan 20194:09 pmRNSDirector/PDMR Shareholding
17th Dec 201812:22 pmRNSChange of Director's Details
5th Dec 20187:00 amRNSOperations update
3rd Dec 20187:00 amRNSCompletion of Magnus Transaction
26th Nov 201811:56 amRNSDirector/PDMR Shareholding
16th Nov 201812:10 pmRNSHolding(s) in Company
1st Nov 20182:29 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.